Author:
Kurita Akinobu,Kado Shoichi,Matsumoto Tsuneo,Asakawa Naoyuki,Kaneda Norimasa,Kato Ikuo,Uchida Kazumi,Onoue Masaharu,Yokokura Teruo
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference36 articles.
1. Abigerges D, Armand J-P, Chabot GG, da Costa L, Fadel E, Cote C, Hérait P, Gandia D (1994) Irinotecan (CPT-11) high-dose escalation using intensive high-dose loperamide to control diarrhea. J Natl Cancer Inst 86:446–449
2. Ando Y, Saka H, Ando M, Sawa T, Muro K, Ueoka H, Yokoyama A, Saitoh S, Shimokata K, Hasegawa Y (2000) Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis. Cancer Res 60:6921–6926
3. Atsumi R, Suzuki W, Hakusui H (1991) Identification of metabolites of irinotecan, a new derivative of camptothecin, in the rat bile and its biliary excretion. Xenobiotica 21:1159–1169
4. De Jong FA, Kehrer DFS, Mathijssen RHJ, Creemers GJ, de Bruijn P, van Schaik RHN, Planting AST, van der Gaast A, Eskens FAL, Janssen JTP, Ruit JB, Verweij J, Sparreboom A, de Jonge MJA (2006) Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study. Oncologist 11:944–954
5. Fukuoka M, Niitani H, Suzuki A, Motomiya M, Hasegawa K, Nishiwaki Y, Kuriyama T, Ariyoshi Y, Negoro S, Masuda N, Nakajima S, Taguchi T (1992) A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer (see comment citation in Medline). J Clin Oncol 10:16–20
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献